News

AZoLifeSciences on MSN5h
Uncovering How Cholera Evaded Phages For Epidemic Success
Cholera bacteria engage in microscopic battles with phages, influencing pandemic dynamics and highlighting the role of viral ...
Understanding how cholera bacteria resist phage predation
When we think of cholera, most of us picture contaminated water and tragic outbreaks in vulnerable regions. But behind the scenes, cholera bacteria are locked in a fierce, microscopic war-one that ...
NDTV Profit on MSN2d
Bharat Biotech's cholera vaccine 'Hillchol' clears phase-III trials
Bharat Biotech International Ltd on Wednesday said its oral Cholera Vaccine Hillchol has successfully completed phase III ...
Bharat Biotech’s oral cholera vaccine Hillchol shows ‘success’ in Phase III clinical studies
Bharat Biotech's Hillchol OCV, effective against cholera serotypes, aims to provide affordable, accessible vaccines for ...
Bharat Biotech successfully completes Phase III trials of new oral cholera vaccine Hillchol
Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving ...
The Financial Express2d
Amid global shortage, Bharat Biotech to launch oral cholera vaccine
Bharat Biotech to launch Hillchol, its oral cholera vaccine, amid a global shortage. With Phase III trials completed and 200M ...
Bharat Biotech's oral cholera vaccine Hillchol clears phase 3 trials
In this study, participants were divided into three age groups: adults over 18 years, children aged 5 to under 18 years, and ...
The Print2d
Bharat Biotech’s cholera vaccine successfully completes Phase-III trials
Bharat Biotech International Ltd on Wednesday said its oral Cholera Vaccine Hillchol has successfully completed phase III ...